Arcutis Biotherapeutics, Inc. 10-K filing
Filed 2026-02-25 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001787306-26-000018
- Form type
- 10-K
- CIK
- 0001787306
- Primary document
- https://www.sec.gov/Archives/edgar/data/1787306/000178730626000018/arqt-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Arcutis Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $376.1M | - | - |
| Cost Of Revenue | $36.7M | - | - |
| Operating Income | $-12.2M | - | - |
| Net Income | $-16.1M | - | - |
| Eps Basic | -0.13 | - | - |
| Eps Diluted | -0.13 | - | - |
| Cash And Equivalents | $42.9M | - | - |
| Total Assets | $433.0M | - | - |
| Total Liabilities | $243.5M | - | - |
| Shareholders Equity | $189.5M | - | - |
| Operating Cash Flow | $-5.6M | - | - |
| Capital Expenditures | $686,000 | - | - |